In insulin resistant and in type 2 diabetic rats, the occurrence of an insulin- and PTH-independent bone anabolic action mediated by GLP-1 has been demonstrated, together with an osteogenic action on altered bone structure on osteoblasts. Here, GLP1R is linked to type 2 diabetes mellitus.